Medical Developments International Limited (MVP.AX)
Medical Developments International Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Scoresby, VIC, AU. The stock last traded at $0.45, down 6.25% on the session, giving a market capitalisation of $50.7M. Its beta of 1.41 implies it has historically moved more than the broad market.
Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Medical Developments International Limited is most often compared with the following Healthcare names: